Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL) disclosed that it repurchased 19,000 ordinary shares on 11 June 2026 through on-market transactions on the Hong Kong Stock Exchange.

The shares were bought at prices ranging between HKD 1.01 and HKD 1.03, translating into a volume-weighted average repurchase cost of HKD 1.02 per share and an aggregate cash outlay of HKD 19,349.60. All repurchased shares have been retained as treasury shares; none were cancelled.

Following the transaction: • Issued shares (excluding treasury shares) decreased to approximately 1.03 billion from 1.03 billion previously, representing a marginal reduction of 0.00184%. • Treasury shares increased to about 7.14 million, up from 7.12 million. • Total issued shares, including treasury shares, remained unchanged at roughly 1.04 billion.

The buyback was carried out under the repurchase mandate approved on 5 June 2026, which permits the company to repurchase up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 96,500 shares, equivalent to 0.00933% of the issued share capital on the mandate date.

In line with Hong Kong listing rules, KINDSTAR GLOBAL is subject to a moratorium on issuing new shares or selling treasury shares until 11 July 2026.